Movectro cladribine tablets regulatory update

The Australian Therapeutic Goods Administration (TGA) approved Movectro cladrbine tablets from Merck's Merck Serono S.A. unit to treat relapsing-remitting multiple sclerosis (RRMS). The purine nucleo...